| Form | Liquid |
|---|---|
| Host Species | Human |
| Clonality | Monoclonal |
| Isotype | IgG1, kappa |
| Purity | >95% as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin Level | < 10 EU/mg |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Species Reactivity | Human |
| Storage Buffer | 0.01 M PBS pH 7.4 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -97°C long term. |
| Product Usage Information | ELISA: 1:2000-1:20000 |
| Accession Number | P15692 |
| Background | Vascular endothelial growth factor A, long form (VEGFA) is a ~43 kDa protein. Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A. Involved in protecting cells from hypoxia-mediated cell death. VEGFA is the therapeutic target of bevacizumab (Avastin). 1. Katsman, M. et al. (2022) Cells 11. PMID: 35455969 |
| Note | For research use only. |
| Product Name | Clicks |
|---|---|
| 痢疾志贺氏菌单克隆抗体 | 7715 |
| 沙门氏菌单克隆抗体 | 7533 |
| 乙型副伤寒沙门氏菌单克隆抗体 | 8047 |
| A族链球菌单克隆抗体 | 7662 |
| 甲型副伤寒沙门氏菌单抗 | 7388 |
| 麻疹病毒单克隆抗体 | 7739 |
| HBeAg单克隆抗体 | 7589 |
| 新型冠状病毒(SARS-COV-2)NP蛋白单克隆抗体 | 7075 |
| 呼吸道腺病毒单克隆抗体 | 7825 |
| 大肠杆菌单克隆抗体 | 7786 |
| LP-PLA2单克隆抗体 | 7824 |
| NT-PROBNP单克隆抗体 | 7492 |
| 半乳糖凝集素3单克隆抗体 | 7429 |
| D二聚体单克隆抗体 | 7505 |
| 肌钙蛋白单克隆抗体 | 7773 |
| 肌红蛋白单克隆抗体 | 7696 |
| AAT单克隆抗体 | 7462 |
| 人SAA单克隆抗体 | 7323 |
| 黏病毒抗性蛋白A单克隆抗体 | 7663 |
| 降钙素原单克隆抗体 | 7296 |